Polymeric article for dispensing drugs

Claim 2

An article for controllably dispensing drugs, comprising: a. crystalline polyethylene having a melting point of at least 100° C. formed into a solid shape which has structural integrity; and b. from about 0.5% to about 50% by weight based on said polyethylene of an addictive drug antagonist present in an antagonistically effective amount and substantially uniformly and intimately dispersed throughout portions of said shaped polyethylene with an outer surface of said solid shape comprising means for diffusing said drug antagonist therethrough with said drug antagonist exuding to said outer surface.

Claim 3

A controlled release drug dispenser comprising an intimate mixture of crystalline polyethylene having a melting point of at least about 100° C. and an addictive drug antagonist present in an antagonistically effective amount, said mixture being formed into a solid shape having structural integrity.

Claim 4

A controlled release drug dispenser comprising an intimate mixture of crystalline polyethylene having a melting point of at least about 100° C. and an addictive drug antagonist present in an antagonistically effective amount, said mixture being formed into a solid shape having structural integrity.

Claim 5

In the art of administering effective amounts of an addictive drug antagonist to a taker of an addictive drug which can be taken while the blood still contains the antagonist, the improvement which consists essentially of the steps of subcutaneously implanting in the body of an ambulatory, nonconfined drug addict a shaped article having structural integrity, said shaped article being formed from a crystalline polymeric material having a melting point of at least about 100° C., said article having dispersed therein an effective amount of an addictive drug antagonist, thereby extending the ambulatory, nonconfined addict's period of cure beyond the time of actual clinical confinement.

Claim 6

In the art of administering effective amounts of an addictive drug antagonist to a taker of an addictive drug which can be taken while the blood still contains the antagonist, the improvement which consists essentially of the steps of subcutaneously implanting in the body of an ambulatory, nonconfined drug addict a shaped article having structural integrity, said shaped article being formed from a crystalline polymeric material having a melting point of at least about 100° C., said article having dispersed therein an effective amount of an addictive drug antagonist, thereby extending the ambulatory, nonconfined addict's period of cure beyond the time of actual clinical confinement.

Claim 7

An improvement of claim 3 wherein said polymeric material comprises polyethylene.

Claim 8

In the art of contraception by means of an intrauterine device, the improvement which consists essentially of the step of offering the added protection of an exuding contraceptive drug in effective amounts by inserting into the uterus of a woman an intrauterine device formed from a crystalline polymeric material having a melting point of at least about 100° C., said crystalline polymeric material having intimately dispersed therethrough an effective amount of a contraceptive drug.

Claim 9

In the art of contraception by means of an intrauterine device, the improvement which consists essentially of the step of offering the added protection of an exuding contraceptive drug in effective amounts by inserting into the uterus of a woman an intrauterine device formed from a crystalline polymeric material having a melting point of at least about 100° C., said crystalline polymeric material having intimately dispersed therethrough an effective amount of a contraceptive drug.

Claim 10

An intrauterine device comprising: a. a crystalline polymeric material formed into the shape of an intrauterine device; and, b. a contraceptive drug uniformly and intimately dispersed throughout said intrauterine device, said drug being present in an effective contraceptive amount.

Claim 11

An intrauterine device comprising: a. a crystalline polymeric material formed into the shape of an intrauterine device; and, b. a contraceptive drug uniformly and intimately dispersed throughout said intrauterine device, said drug being present in an effective contraceptive amount.

Claim 12

An intrauterine device of claim 6 wherein said contraceptive drug comprises an estrogen or a progestin or a combination of an estrogen and a progestin.

Claim 13

An intrauterine device of claim 6 wherein said contraceptive drug comprises a spermicidal agent.